Evidence map›Paper›PMID 36606510›Full record

Trial reportEndocrinology, diabetes & metabolism2023

A clinical trial about effects of prebiotic and probiotic supplementation on weight loss, psychological profile and metabolic parameters in obese subjects.

Rym Ben Othman, Nadia Ben Amor, Faten Mahjoub, Olfa Berriche, Chaima El Ghali, Amel Gamoudi, Henda Jamoussi

Open access · goldFull text readClinical Trial
In one paragraph

Trial report in Endocrinology, diabetes & metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 3 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 3 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Review
  10. Review
  11. Review
  12. The Genetic Blueprint of Obesity: From Pathogenesis to Novel Therapies.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rym Ben OthmanFaculty of Medicine of Tunis, Institute National de Nutrition et de Technologie Alimentaire de Tunis and University of Tunis el Manar, Tunis, Tunisia.ORCID 0000-0002-2453-9778
Nadia Ben AmorFaculty of Medicine of Tunis, Institute National de Nutrition et de Technologie Alimentaire de Tunis and University of Tunis el Manar, Tunis, Tunisia.
Faten MahjoubFaculty of Medicine of Tunis, Institute National de Nutrition et de Technologie Alimentaire de Tunis and University of Tunis el Manar, Tunis, Tunisia.
Olfa BerricheFaculty of Medicine of Tunis, Institute National de Nutrition et de Technologie Alimentaire de Tunis and University of Tunis el Manar, Tunis, Tunisia.
Chaima El GhaliFaculty of Medicine of Tunis, Institute National de Nutrition et de Technologie Alimentaire de Tunis and University of Tunis el Manar, Tunis, Tunisia.
Amel GamoudiFaculty of Medicine of Tunis, Institute National de Nutrition et de Technologie Alimentaire de Tunis and University of Tunis el Manar, Tunis, Tunisia.
Henda JamoussiFaculty of Medicine of Tunis, Institute National de Nutrition et de Technologie Alimentaire de Tunis and University of Tunis el Manar, Tunis, Tunisia.
Institut National de Nutrition et de Technologie Alimentaire · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe management of obesity is difficult with many failures of lifestyle measures, hence the need to broaden the range of treatments prescribed. The aim of our work was to study the influence of pre and probiotics on weight loss psychological profile and metabolic parameters in obese patients.

methodsIt is a clinical trial involving 45 obese patients, recruited from the Obesity Unit of the National Institute of Nutrition between March and August 2022 divided into three groups: diet only (low-carbohydrate and reduced energy diet), prebiotics (30 g of carob/day) and probiotics (one tablet containing Bifidobacterium longum, Lactobacillus helveticus, Lactococcus lactis, Streptococcus thermophilus/day). The three groups were matched for age, sex and BMI. Patients were seen after 1 month from the intervention. Anthropometric measures, biological parameters, dietary survey and psychological scores were performed.

resultsThe average age of our population was 48.73 ± 7.7 years, with a female predominance. All three groups showed a significant decrease in weight, BMI and waist circumference with p < .05. Only the prebiotic and probiotic group showed a significant decrease in fat mass (p = .001) and a significant increase in muscle strength with p = .008 and .004, but the differences were not significant between the three groups. Our results showed also a significant decrease in insulinemia and HOMA-IR in the prebiotic group compared to the diet-alone group (p = .03; p = .012) and the probiotic group showed a significant decrease in fasting blood glucose compared to the diet alone group (p = .02). A significant improvement in sleep quality was noted in the prebiotic group (p = .02), with a significant decrease in depression, anxiety and stress in all three groups.

conclusionsThe prescription of prebiotics and probiotics with the lifestyle measures seems interesting for the management of obesity especially if it is sarcopenic, in addition to the improvement of metabolic parameters and obesity-related psychiatric disorders.

Indexed as

PrebioticsProbioticsAdultDietFemaleHumansMaleMiddle AgedObesityWeight LossPrebioticsobesityprebioticsprobioticsweight loss

Identifiers

PMID36606510
PMCPMC10000630
OpenAlexW4313575587

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read28
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.